Published in Clin Exp Immunol on November 01, 1970
Tissue transplantation: a new approach to the "typing" problem. Br Med J (1963) 3.16
Interaction between 'sensitized lymphocytes' and antigen in vitro. I. The release of a skin reactive factor. Immunology (1969) 1.82
Immunological features of idiopathic Addison's disease: an antibody to cells producing steroid hormones. Clin Exp Immunol (1968) 1.53
A STUDY OF THE CHEMICAL REACTIONS BETWEEN CHROMIUM AND SKIN. J Invest Dermatol (1964) 1.44
Studies on the ability of the soluble proteins from skin, painted in vivo with DNFB, to cause contact sensitivity in the guinea pig. Int Arch Allergy Appl Immunol (1970) 1.05
Adoptive cutaneous anaphylaxis: a technique for studying antibody globulin synthesis. J Immunol (1966) 0.86
Immunological phenomena in leprosy and related diseases. Adv Immunol (1971) 5.55
Selective depletion of lymphoid tissue by cyclophosphamide. Clin Exp Immunol (1972) 5.29
Functional aspects of the selective depletion of lymphoid tissue by cyclophosphamide. Immunology (1972) 5.18
Reduced lymphocyte transformation due to a plasma factor in patients with active syphilis. Lancet (1969) 4.92
Central and peripheral effects of anti-lymphocyte sera. Lancet (1967) 3.76
Erythema nodosum leprosum: a clinical manifestation of the arthus phenomenon. Lancet (1969) 3.67
Reversal of immunological tolerance by cyclophosphamide through inhibition of suppressor cell activity. Nature (1974) 3.38
B-cell suppression of delayed hypersensitivity reactions. Nature (1974) 3.37
Further studies on B-lymphocyte suppression in delayed hypersensitivity, indicating a possible mechanism for Jones-Mote hypersensitivity. Immunology (1973) 2.65
The biological activities of soluble lymphocyte products. Clin Exp Immunol (1972) 2.58
Studies on the origin and reactive ability in vivo of peritoneal exudate cells in delayed hypersensitivity. Int Arch Allergy Appl Immunol (1967) 2.51
Suppressor cells in normal immunisation as a basic homeostatic phenomenon. Nature (1974) 2.23
Cell-mediated immunity in patients with leprosy. Lancet (1969) 2.21
Allertic complications of meningococcal disease. I. Clinical aspects. Br Med J (1973) 2.20
Complement in acute inflammation. J Pathol (1969) 2.20
Detection of mycobacterial rRNA in sarcoidosis with liquid-phase hybridisation. Lancet (1992) 2.11
A study of the passive cellular transfer of local cutaneous hypersensitivity. I. Passive transfer of delayed hypersensitivity in inbred and outbred guinea-pigs. Int Arch Allergy Appl Immunol (1965) 2.09
An analysis of the effects of some types of anti-lymphocyte sera on contact hypersensitivity and certain models of inflammation. Immunology (1968) 2.07
New antibody in early syphilis. Lancet (1970) 1.97
Cytology of the induction of hypersensitivity. Br Med Bull (1967) 1.95
Evidence for circulating immune complexes in lepromatous leprosy. Lancet (1972) 1.94
Interaction between "sensitized lymphocytes" and antigen in vitro. II. Mitogen-induced release of skin reactive and macrophage migration inhibitory factors. Cell Immunol (1970) 1.93
Immunological basis for depression of cellular immunity and the delayed allergic response in patients with lepromatous leprosy. Lancet (1968) 1.88
Electrophoretic mobility of guinea pig peritoneal exudate cells in hypersensitivity reactions. Int Arch Allergy Appl Immunol (1968) 1.88
Interaction between 'sensitized lymphocytes' and antigen in vitro. I. The release of a skin reactive factor. Immunology (1969) 1.82
Immunological significance of changes in lymph nodes across the leprosy spectrum. Clin Exp Immunol (1971) 1.76
Effect of lymphocyte mediators on macrophages in vitro. A correlation of morphological and cytochemical changes. Clin Exp Immunol (1973) 1.73
Studies on the ability of the subcellular fractions of epidermis, painted in vivo with DNFB, to cause contact sensitization in the guinea pig. Int Arch Allergy Appl Immunol (1970) 1.66
The effect of prolonged treatment with antilymphocyte serum on the course of infections with BCG and Leishmania enriettii in the guinea-pig. J Pathol (1971) 1.66
Control of established experimental allergic encephalomyelitis by inhibition of tumor necrosis factor (TNF) activity within the central nervous system using monoclonal antibodies and TNF receptor-immunoglobulin fusion proteins. Eur J Immunol (1994) 1.61
Lymphocyte response to antigens. A. Afferent side of sensitization arc. Response of lymphocytes to antigens. Transplantation (1967) 1.58
Studies on the induction of immunological tolerance by antigen in guinea-pigs already sensitized to dinitrochlorobenzene. Clin Exp Immunol (1971) 1.55
Granuloma formation in lymph-nodes. J Pathol (1970) 1.54
Bleeding and cupping. Ann R Coll Surg Engl (1983) 1.53
The immunogenicity of dinitrophenyl amino acids. J Exp Med (1969) 1.52
Cell-mediated immunity and lymphocyte transformation in syphilis. Proc R Soc Med (1971) 1.48
Control mechanisms in delayed-type hypersensitivity. Br Med Bull (1976) 1.48
Reversal by cyclophosphamide of tolerance in contact sensitization. Tolerance induced by prior feeding with DNCB. Immunology (1975) 1.46
Expression of vascular addressins and ICAM-1 by endothelial cells in the spinal cord during chronic relapsing experimental allergic encephalomyelitis in the Biozzi AB/H mouse. Immunology (1991) 1.44
Surface markers on lymphocytes and cells of the mononuclear phagocyte series in skin sections in leprosy. J Pathol (1978) 1.42
Effect of cyclophosphamide on immunological control mechanisms. Immunol Rev (1982) 1.40
Preliminary results on the purification of the chemical sensitizing agents in alcyonidium gelatinosum. Proc R Soc Med (1966) 1.39
Denatured muscle grafts for nerve repair. An experimental model of nerve damage in leprosy. J Bone Joint Surg Br (1990) 1.39
Metchnikoff revisited. J R Soc Med (1991) 1.36
Ultrastructure of cells present in lymph nodes during the development of contact sensitivity. Int Arch Allergy Appl Immunol (1966) 1.34
Mechanisms of reactions in leprosy. Int J Lepr Other Mycobact Dis (1972) 1.33
Immunological significance of lysosomes with lymphocytes in vivo. Nature (1965) 1.32
Cell-mediated immunological processes in leprosy. Bull World Health Organ (1969) 1.31
Release of skin reactive factor from guinea-pig lymphocytes by mitogens. Nature (1970) 1.30
Basophilic leukocytes in delayed hypersensitivity reactions. J Immunol (1974) 1.29
Scapuloperoneal syndrome type Kaeser and a wide phenotypic spectrum of adult-onset, dominant myopathies are associated with the desmin mutation R350P. Brain (2007) 1.26
The induction of contact hypersensitivity to dinitrochlorobenzene (DNCB) in guinea-pigs by dinitrophenyl-amino acids. Int Arch Allergy Appl Immunol (1966) 1.26
Comparison of mycobacterial granulomas in guinea-pig lymph nodes. J Pathol (1982) 1.25
Epicutaneous induction of hyporeactivity in contact sensitization. Demonstration of suppressor cells induced by contact with 2,4-dinitrothiocyanatebenzene. Immunology (1975) 1.25
An experimental model for the investigation of the cellular basis of desensitization in contact sensitivity. Int Arch Allergy Appl Immunol (1965) 1.24
The immunological significance of histological changes in the spleen and liver in mouse malaria. Clin Exp Immunol (1973) 1.23
The relation of immune depression and B-cell stimulation during the development of delayed hypersensitivity to soluble antigens. Immunology (1977) 1.23
AIDS and leprosy. Lepr Rev (1988) 1.21
Studies on contact hypersensitivity to chromium compounds. Prog Allergy (1973) 1.21
The genetic control of contact sensitization to inorganic metal compounds in guinea-pigs. Immunology (1968) 1.20
Dissociation between delayed-type hypersensitivity and resistance to pathogenic mycobacteria demonstrated by T-cell clones. Infect Immun (1987) 1.20
Sensitization, immunological tolerance and desensitization of guinea pigs to neoarsphenamine. IV. Desensitization to NEO. Int Arch Allergy Appl Immunol (1966) 1.19
Induction of chronic relapsing experimental allergic encephalomyelitis in Biozzi mice. J Neuroimmunol (1990) 1.18
Studies on the effect of systemic administration of sensitizers in guinea-pigs with contact sensitivity to inorganic metal compounds. II. The flare-up of previous test sites of contact sensitivity and the development of a generalized rash. Clin Exp Immunol (1968) 1.17
Effects of cyclophosphamide on lymphoid tissues labelled with 5-iodo-2-deoxyuridine- 125 I and 51 Cr. Int Arch Allergy Appl Immunol (1972) 1.16
Mechanisms involved in the expression of Jones-Mote hypersensitivity. I. Passive cell transfer studies. Cell Immunol (1975) 1.16
Delayed pressure urticaria. Br J Dermatol (1968) 1.16
Release of soluble factors from lymph nodes containing mycobacterial granulomas and their effect on fibroblast function in vitro. Cell Immunol (1981) 1.15
Activation of the alternative pathway of complement by mycobacteria and cord factor. Infect Immun (1980) 1.14
H-2 linkage control of resistance to subcutaneous infection with Mycobacterium lepraemurium. Infect Immun (1982) 1.14
Studies on the effect of soluble lymphocyte products (lymphokines) on macrophage physiology. II. Cytochemical changes associated with activation. Cell Immunol (1975) 1.14
A sensitive technique for measuring specific macrophage aggregation: a comparison with macrophage migration inhibition, for the detection of lymphokine activity. Immunology (1979) 1.12
The value of an assessment of erythema and increase in thickness of the skin reaction for a full appreciation of the nature of delayed hypersensitivity in the guinea pig. Int Arch Allergy Appl Immunol (1977) 1.11
Modification of cutaneous leishmaniasis in the guinea-pig by cyclophosphamide. Clin Exp Immunol (1976) 1.11
Nephrotic syndrome due to ammoniated mercury. Br J Dermatol (1968) 1.10
Dissociation between lymph node and peripheral reactivity in immunological unresponsiveness to DNCB. Immunology (1973) 1.10
Immunological tolerance in contact-hypersensitivity to dinitrochlorobenzene. Dose and time dependence. Possible cellular kinetics. Immunology (1971) 1.10
Suppression of delayed hypersensitivity to tuberculin by antigenic competition. A positive immunoregulatory mechanism sensitive to cyclophosphamide. Immunology (1981) 1.09
A lack of correlation between antigen-specific cellular reactions and resistance to Mycobacterium lepraemurium infection in mice. Immunology (1981) 1.08
Denatured autologous muscle graft in leprosy. Lancet (1991) 1.08
Mitsuda-type lepromin reactions as a measure of host resistance in Mycobacterium lepraemurium infection. Infect Immun (1979) 1.08
Changes in macrophages in vivo induced by desensitization. Cell Immunol (1976) 1.08
Cytokines in the central nervous system of mice during chronic relapsing experimental allergic encephalomyelitis. Cell Immunol (1991) 1.08
Chronic malarial infection in Balb/C mice. Effect on the immune response to sheep erythrocytes and histological changes in the liver and spleen. Trans R Soc Trop Med Hyg (1975) 1.07
Studies on contact sensitivity to chromium in the guinea pig. The role of valence in the formation of the antigenic determinant. J Invest Dermatol (1983) 1.06
An analysis of the multiplicity of the effects of antilymphocyte serum. A comparison with the action of other immunosuppressive agents in the cell-mediated immune response and non-specific inflammation. Antibiot Chemother (1969) 1.06
Granuloma formation in normal guinea pigs injected intradermally with aluminum and zirconium compounds. J Invest Dermatol (1977) 1.05
Studies on the ability of the soluble proteins from skin, painted in vivo with DNFB, to cause contact sensitivity in the guinea pig. Int Arch Allergy Appl Immunol (1970) 1.05
Studies on the effect of systemic administration of sensitizers in guinea-pigs with contact sensitivity to inorganic metal compounds. I. The induction of immunological unresponsiveness in already sensitized animals. Clin Exp Immunol (1968) 1.04
Isolation and characterization of cells infiltrating the spinal cord during the course of chronic relapsing experimental allergic encephalomyelitis in the Biozzi AB/H mouse. Cell Immunol (1993) 1.04
The origin, morphology, and function of epithelioid cells. Immunobiology (1982) 1.04
The relation between B-cell stimulation and delayed hypersensitivity. The effect of cyclophosphamide pretreatment on antibody production. Immunology (1977) 1.03